KELSEY MARTIN: Open Payments
NPI 1619478559 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,140 in 140 payments from 35 companies in 2025. Trend: 2023 $6,894 · 2024 $16,681 · 2025 $17,140
Speaker / faculty: $8,730Travel & lodging: $5,257Food & beverage: $3,109Education: $43
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 39 | $14,813 |
| Regeneron Healthcare Solutions, Inc. | 12 | $369 |
| Merck Sharp & Dohme LLC | 8 | $229 |
| AstraZeneca Pharmaceuticals LP | 9 | $206 |
| Novartis Pharmaceuticals Corporation | 6 | $155 |
| Janssen Biotech, Inc. | 9 | $148 |
| Daiichi Sankyo Inc. | 5 | $128 |
| PFIZER INC. | 5 | $88 |
| Eisai Inc. | 3 | $77 |
| Celgene Corporation | 4 | $75 |
Products named: Trodelvy, LIBTAYO, Enhertu, KISQALI, WELIREG, DUPIXENT, AYVAKIT, RYBREVANT.
Industry payments across TN — which companies pay providers there.
